Scheja A - Search Results

1

The association of antinuclear antibodies with organ involvement and survival in systemic sclerosis.

Hesselstrand R, Scheja A, Shen GQ, Wiik A, Akesson A. Hesselstrand R, et al. Among authors: scheja a. Rheumatology (Oxford). 2003 Apr;42(4):534-40. doi: 10.1093/rheumatology/keg170. Rheumatology (Oxford). 2003. PMID: 12649400

2

Managing work life with systemic sclerosis.

Sandqvist G, Hesselstrand R, Scheja A, Håkansson C. Sandqvist G, et al. Among authors: scheja a. Rheumatology (Oxford). 2012 Feb;51(2):319-23. doi: 10.1093/rheumatology/ker324. Epub 2011 Oct 22. Rheumatology (Oxford). 2012. PMID: 22019802

3

Serum levels of aminoterminal type III procollagen peptide and hyaluronan predict mortality in systemic sclerosis.

Scheja A, Akesson A, Hørslev-Petersen K. Scheja A, et al. Scand J Rheumatol. 1992;21(1):5-9. doi: 10.3109/03009749209095054. Scand J Rheumatol. 1992. PMID: 1570489

4

Inverse relation between plasma concentration of von Willebrand factor and CrEDTA clearance in systemic sclerosis.

Scheja A, Eskilsson J, Akesson A, Wollheim FA. Scheja A, et al. J Rheumatol. 1994 Apr;21(4):639-42. J Rheumatol. 1994. PMID: 8035386

5

Comparison of high frequency (20 MHz) ultrasound and palpation for the assessment of skin involvement in systemic sclerosis (scleroderma).

Scheja A, Akesson A. Scheja A, et al. Clin Exp Rheumatol. 1997 May-Jun;15(3):283-8. Clin Exp Rheumatol. 1997. PMID: 9177923

6

Mortality and causes of death in a Swedish series of systemic sclerosis patients.

Hesselstrand R, Scheja A, Akesson A. Hesselstrand R, et al. Among authors: scheja a. Ann Rheum Dis. 1998 Nov;57(11):682-6. doi: 10.1136/ard.57.11.682. Ann Rheum Dis. 1998. PMID: 9924211 Free PMC article.

7

Capillary density in patients with systemic sclerosis, as determined by microscopy counts and compared with computer-based analysis.

Wildt M, Hesselstrand R, Scheja A, Akesson A. Wildt M, et al. Among authors: scheja a. Clin Exp Rheumatol. 1999 Mar-Apr;17(2):219-22. Clin Exp Rheumatol. 1999. PMID: 10342049

8

Circulating collagen metabolites in systemic sclerosis. Differences between limited and diffuse form and relationship with pulmonary involvement.

Scheja A, Wildt M, Wollheim FA, Akesson A, Saxne T. Scheja A, et al. Rheumatology (Oxford). 2000 Oct;39(10):1110-3. doi: 10.1093/rheumatology/39.10.1110. Rheumatology (Oxford). 2000. PMID: 11035131

9

The association between changes in skin echogenicity and the fibroblast production of biglycan and versican in systemic sclerosis.

Hesselstrand R, Westergren-Thorsson G, Scheja A, Wildt M, Akesson A. Hesselstrand R, et al. Among authors: scheja a. Clin Exp Rheumatol. 2002 May-Jun;20(3):301-8. Clin Exp Rheumatol. 2002. PMID: 12102465

10

Screening for pulmonary hypertension in systemic sclerosis: the longitudinal development of tricuspid gradient in 227 consecutive patients, 1992-2001.

Hesselstrand R, Ekman R, Eskilsson J, Isaksson A, Scheja A, Ohlin AK, Akesson A. Hesselstrand R, et al. Among authors: scheja a. Rheumatology (Oxford). 2005 Mar;44(3):366-71. doi: 10.1093/rheumatology/keh486. Epub 2004 Nov 23. Rheumatology (Oxford). 2005. PMID: 15561735

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

77 results

Search Page

Filters